Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. POM
POM logo

POM Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
0.323
Open
0.323
VWAP
0.32
Vol
27.18K
Mkt Cap
39.33M
Low
0.323
Amount
8.79K
EV/EBITDA(TTM)
--
Total Shares
119.19M
EV
361.06M
EV/OCF(TTM)
--
P/S(TTM)
--
PomDoctor Ltd is a holding company principally engaged in operating a online medical services platform for chronic diseases. The Company operates its businesses through two segments. The Internet Hospital segment mainly engaged in providing online follow-up consultations and online prescription renewal service to customers and also sells prescription to customers through the website and apps. The Pharmaceutical Supply Chain segment mainly engaged in pharmacy retail sales and wholesale. The Company mainly operates its businesses in the domestic market.
Show More

Events Timeline

(ET)
2026-02-02
06:10:00
PomDoctor Receives Nasdaq Deficiency Notice
select
2025-12-10 (ET)
2025-12-10
09:40:00
Pepco Holdings, Inc. Trading Resumes
select
2025-12-10
09:40:00
Pepco Holdings Trading Halted Due to Volatility
select
2025-10-08 (ET)
2025-10-08
11:36:22
PomDoctor Debuts at $4.50 After IPO Set at $4.00 per Share
select
2025-10-08
08:03:04
PomDoctor Sets IPO Price at $4.00 for 5 Million Shares
select

News

Globenewswire
7.0
03-24Globenewswire
Investigation into Pomdoctor Securities Litigation Announced
  • Legal Investigation: Faruq & Faruq, LLP is investigating potential claims against Pomdoctor Limited, specifically urging investors who purchased securities between October 9, 2025, and December 11, 2025, to apply for lead plaintiff status in a federal securities class action by the April 13, 2026 deadline.
  • Stock Price Plunge: Pomdoctor's stock price fell from approximately $0.50 on December 10, 2025, to about $0.38 the following day, representing a decline of roughly $0.12 or 24% in a single trading session, reflecting widespread investor concerns regarding the company's financial performance and valuation.
  • False Promotion Allegations: The complaint alleges that Pomdoctor and its executives violated federal securities laws by making false and misleading statements and failing to disclose fraudulent stock promotion schemes involving social media misinformation, leading to investor misconceptions about the company's prospects.
  • Investor Rights Protection: Faruq & Faruq encourages anyone with information regarding Pomdoctor's conduct, including whistleblowers and former employees, to contact the firm directly to provide information for potential legal actions, ensuring the protection of investor rights.
PRnewswire
7.0
03-22PRnewswire
Pomdoctor Investors Encouraged to Seek Legal Options
  • Legal Investigation Initiated: Faruq & Faruqi LLP is investigating potential claims against Pomdoctor, particularly for investors who purchased securities between October 9, 2025, and December 11, 2025, aiming to protect investors' legal rights.
  • Claim Deadline Reminder: Investors should note that the deadline to seek the role of lead plaintiff in the federal securities class action is April 13, 2026, making this time frame critical for asserting their claims.
  • Direct Contact Encouragement: Securities Litigation Partner Josh Wilson encourages affected investors to reach out directly, providing multiple contact numbers to facilitate consultations, demonstrating the firm's commitment to client support.
  • Potential Impact Assessment: This investigation could negatively affect Pomdoctor's stock price and market confidence, prompting investors to stay informed about their legal options to take action if necessary.
Globenewswire
7.0
03-21Globenewswire
PomDoctor Securities Class Action Reminder
  • Class Action Notice: Rosen Law Firm reminds investors who purchased PomDoctor Ltd. (NASDAQ: POM) securities between October 9 and December 11, 2025, to apply as lead plaintiffs by April 7, 2026, to potentially receive compensation without any out-of-pocket fees.
  • Lawsuit Background: The lawsuit alleges that during the class period, PomDoctor was involved in a fraudulent stock promotion scheme that misled investors through social media misinformation and insider trading, which inflated stock prices and misrepresented the company's operations.
  • Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest settlement against a Chinese company, recovering over $438 million for investors in 2019 alone, highlighting its strong track record in this legal domain.
  • Investor Guidance: Investors are advised to carefully select legal counsel, with Rosen Law Firm recommending attorneys with proven success in class actions to ensure effective representation in the litigation process.
PRnewswire
7.0
03-21PRnewswire
Reminder for PomDoctor Securities Class Action
  • Class Action Notice: Rosen Law Firm reminds investors who purchased PomDoctor Ltd. (NASDAQ:POM) securities between October 9 and December 11, 2025, to apply as lead plaintiffs by April 7, 2026, or risk losing the opportunity to represent other investors.
  • Fee Arrangement: Investors joining the PomDoctor class action will incur no out-of-pocket costs, as the law firm operates on a contingency fee basis, which alleviates financial burdens and encourages broader participation in the lawsuit.
  • Lawsuit Background: The lawsuit alleges that PomDoctor was involved in a fraudulent stock promotion scheme during the class period, with insiders using offshore accounts to dump shares, misleading investors and impacting the company's stock price performance.
  • Law Firm's Strength: Rosen Law Firm specializes in securities class actions and has achieved the largest settlement against a Chinese company, demonstrating its expertise and success rate, which investors should consider when selecting legal counsel.
Globenewswire
7.0
03-19Globenewswire
PomDoctor Faces Class Action Lawsuit Over Securities Violations
  • Class Action Initiated: Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against PomDoctor, aiming to recover damages for investors who purchased the company's securities between October 9 and December 11, 2025, highlighting serious investor concerns over potential fraud.
  • Allegations of False Statements: The complaint alleges that PomDoctor failed to disclose significant adverse facts regarding its business, operations, and securities trading activities during the class period, leading to investor misunderstandings that could impact stock prices.
  • Insider Trading Suspicions: The lawsuit further claims that insiders used offshore or nominee accounts to facilitate coordinated share dumping, suggesting improper profit-taking during price manipulation activities, which increases the risk of investor losses.
  • Investor Recourse Opportunity: Affected investors have until April 6, 2026, to request lead plaintiff status, with Bronstein, Gewirtz & Grossman, LLC offering risk-free representation, emphasizing their expertise and successful track record in securities fraud class actions.
Globenewswire
7.0
03-19Globenewswire
Investigation into Pomdoctor Securities Litigation Announced
  • Legal Investigation: Faruq & Faruq, LLP is investigating potential claims against Pomdoctor Limited due to possible false statements made during securities transactions from October 9, 2025, to December 11, 2025, with a deadline for lead plaintiff applications set for April 13, 2026.
  • Stock Price Volatility: Pomdoctor's stock price plummeted from approximately $0.50 to $0.38 between December 10 and 11, 2025, representing a 24% decline in a single trading session, reflecting investor concerns regarding the company's financial performance and eroding market confidence.
  • False Promotion Allegations: The lawsuit alleges that Pomdoctor and its executives violated federal securities laws by failing to disclose involvement in fraudulent stock promotions and insider trading, misleading investors and negatively impacting the company's reputation and market value.
  • Investor Rights Protection: Faruq & Faruq encourages affected investors to contact the firm to provide information supporting the litigation, ensuring that investors can secure their rightful claims in any potential recovery.

Valuation Metrics

The current forward P/E ratio for PomDoctor Ltd (POM.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess PomDoctor Ltd's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

stocks under $1 that will be bullish today
Intellectia · 96 candidates
Price: <= $1.00
Ticker
Name
Market Cap$
top bottom
SXTC logo
SXTC
China SXT Pharmaceuticals Inc
11.70M
SAFX logo
SAFX
XCF Global Inc
28.75M
MKDW logo
MKDW
MKDWELL Tech Inc
14.59M
SRXH logo
SRXH
Srx Health Solutions Inc
11.89M
ADIL logo
ADIL
Adial Pharmaceuticals Inc
6.04M
GRI logo
GRI
GRI Bio Inc
2.26M
stocks under $0.50 with an rsi under 20
Intellectia · 33 candidates
Price: <= $0.50Rsi Category: oversold
Ticker
Name
Market Cap$
top bottom
MTEN logo
MTEN
Mingteng International Corp Inc
5.55M
ATPC logo
ATPC
Agape ATP Corp
4.10M
SXTC logo
SXTC
China SXT Pharmaceuticals Inc
11.70M
CCTG logo
CCTG
CCSC Technology International Holdings Ltd
3.84M
APLT logo
APLT
Applied Therapeutics Inc
14.63M
ZJYL logo
ZJYL
Jin Medical International Ltd
19.82M
stocks under $1 with an rsi under 20
Intellectia · 53 candidates
Price: <= $1.00Rsi Category: oversold
Ticker
Name
Market Cap$
top bottom
AIIO logo
AIIO
Robo.ai Inc
89.22M
PSTV logo
PSTV
Plus Therapeutics Inc
52.05M
HURA logo
HURA
TuHURA Biosciences Inc
41.71M
XLO logo
XLO
Xilio Therapeutics Inc
40.33M
POM logo
POM
PomDoctor Ltd
35.21M
OTLK logo
OTLK
Outlook Therapeutics Inc
32.44M
stocks under $1 with an rsi under 10
Intellectia · 53 candidates
Price: <= $1.00Rsi Category: oversold
Ticker
Name
Market Cap$
top bottom
AIIO logo
AIIO
Robo.ai Inc
89.22M
PSTV logo
PSTV
Plus Therapeutics Inc
52.05M
HURA logo
HURA
TuHURA Biosciences Inc
41.71M
XLO logo
XLO
Xilio Therapeutics Inc
40.33M
POM logo
POM
PomDoctor Ltd
35.21M
OTLK logo
OTLK
Outlook Therapeutics Inc
32.44M
stocks under $1 with an rsi under 15
Intellectia · 53 candidates
Price: <= $1.00Rsi Category: oversold
Ticker
Name
Market Cap$
top bottom
MTEN logo
MTEN
Mingteng International Corp Inc
5.55M
ATPC logo
ATPC
Agape ATP Corp
4.10M
SXTC logo
SXTC
China SXT Pharmaceuticals Inc
11.70M
CCTG logo
CCTG
CCSC Technology International Holdings Ltd
3.84M
APLT logo
APLT
Applied Therapeutics Inc
14.63M
ZJYL logo
ZJYL
Jin Medical International Ltd
19.82M
stovks to buy on wed from 20 to 40 cents
Intellectia · 81 candidates
Price: $0.20 - $0.40
Ticker
Name
Market Cap$
top bottom
SGMO logo
SGMO
Sangamo Therapeutics Inc
127.97M
IXHL logo
IXHL
Incannex Healthcare Inc
123.43M
GPUS logo
GPUS
Hyperscale Data Inc
96.48M
AURE logo
AURE
Aurelion Inc
95.26M
AIIO logo
AIIO
Robo.ai Inc
89.22M
ZONE logo
ZONE
CleanCore Solutions Inc
79.36M

Whales Holding POM

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is PomDoctor Ltd (POM) stock price today?

The current price of POM is 0.3234 USD — it has decreased -2.12

What is PomDoctor Ltd (POM)'s business?

PomDoctor Ltd is a holding company principally engaged in operating a online medical services platform for chronic diseases. The Company operates its businesses through two segments. The Internet Hospital segment mainly engaged in providing online follow-up consultations and online prescription renewal service to customers and also sells prescription to customers through the website and apps. The Pharmaceutical Supply Chain segment mainly engaged in pharmacy retail sales and wholesale. The Company mainly operates its businesses in the domestic market.

What is the price predicton of POM Stock?

Wall Street analysts forecast POM stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for POM is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is PomDoctor Ltd (POM)'s revenue for the last quarter?

PomDoctor Ltd revenue for the last quarter amounts to 16.23 USD, increased 0.12

What is PomDoctor Ltd (POM)'s earnings per share (EPS) for the last quarter?

PomDoctor Ltd. EPS for the last quarter amounts to USD, decreased

How many employees does PomDoctor Ltd (POM). have?

PomDoctor Ltd (POM) has 156 emplpoyees as of March 25 2026.

What is PomDoctor Ltd (POM) market cap?

Today POM has the market capitalization of 39.33M USD.